Literature DB >> 16423055

Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.

Itzhak Mendel1, Ethan M Shevach.   

Abstract

OX40/OX40 ligand (OX40L) interactions have been shown to exert potent costimulatory effects on T-cell activation. OX40 expression is transiently up-regulated on T cells following T-cell receptor engagement, while OX40L is expressed on antigen-presenting cells following activation. Although expression of the OX40L by T cells has been reported, the requirements for induction of OX40L on T cells have not been studied in detail. Here, we demonstrate that the OX40L can be induced on murine CD4(+) and CD8(+) T cells after 6 days of culture under T helper type 1 (Th1) conditions, but not under Th2 conditions. Induction of OX40L expression required a high concentration of interleukin-12 (IL-12), was not seen in the presence of interferon-gamma, and was dependent on signal transducer and activator of transcription type 4 (STAT4). Notably, induction of OX40L on T cells was only seen at very low concentrations of antigen or anti-CD3. T-cell-expressed OX40L was fully capable of delivering a potent costimulatory signal that enhanced the proliferation of CD4(+) T cells as well as promoted their differentiation to Th2 cells. OX40L expression could also be induced on CD4(+) T cells in vivo following immunization with low-dose antigen and an IL-12 inducer. OX40/OX40L interactions between antigen-specific T cells may occur in T-cell zones in lymph node and spleen when OX40L expression has diminished on APC. Costimulation by T-cell-expressed OX40L may result in deviation of a Th1 response to a Th2 response under conditions where T cells are exposed to low concentrations of foreign or autoantigens in the presence of high concentrations of IL-12.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423055      PMCID: PMC1782207          DOI: 10.1111/j.1365-2567.2005.02279.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).

Authors:  S D Pippig; C Peña-Rossi; J Long; W R Godfrey; D J Fowell; S L Reiner; M L Birkeland; R M Locksley; A N Barclay; N Killeen
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

2.  OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors.

Authors:  Mi-Yeon Kim; Vasilios Bekiaris; Fiona M McConnell; Fabrina M C Gaspal; Chandra Raykundalia; Peter J L Lane
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

3.  Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma.

Authors:  Akihiko Hoshino; Yoshitaka Tanaka; Hisaya Akiba; Yumiko Asakura; Yasuo Mita; Takanobu Sakurai; Akiko Takaoka; Shiro Nakaike; Naoto Ishii; Kazuo Sugamura; Hideo Yagita; Ko Okumura
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

4.  The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

Authors:  I Gramaglia; A Jember; S D Pippig; A D Weinberg; N Killeen; M Croft
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

5.  The IL-10-producing competence of Th2 cells generated in vitro is IL-4 dependent.

Authors:  Itzhak Mendel; Ethan M Shevach
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

6.  Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression.

Authors:  Ronald B Smeltz; June Chen; Rolf Ehrhardt; Ethan M Shevach
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.

Authors:  H Akiba; Y Miyahira; M Atsuta; K Takeda; C Nohara; T Futagawa; H Matsuda; T Aoki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

8.  Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand.

Authors:  K Murata; N Ishii; H Takano; S Miura; L C Ndhlovu; M Nose; T Noda; K Sugamura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

9.  Expression of gp34 (OX40 ligand) and OX40 on human T cell clones.

Authors:  N Takasawa; N Ishii; N Higashimura; K Murata; Y Tanaka; M Nakamura; T Sasaki; K Sugamura
Journal:  Jpn J Cancer Res       Date:  2001-04

10.  OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation.

Authors:  Shahram Salek-Ardakani; Jianxun Song; Beth S Halteman; Amha Gebre-Hiwot Jember; Hisaya Akiba; Hideo Yagita; Michael Croft
Journal:  J Exp Med       Date:  2003-07-14       Impact factor: 14.307

View more
  18 in total

Review 1.  Signaling through OX40 enhances antitumor immunity.

Authors:  Shawn M Jensen; Levi D Maston; Michael J Gough; Carl E Ruby; William L Redmond; Marka Crittenden; Yuhuan Li; Sachin Puri; Christian H Poehlein; Nick Morris; Magdalena Kovacsovics-Bankowski; Tarsem Moudgil; Chris Twitty; Edwin B Walker; Hong-Ming Hu; Walter J Urba; Andrew D Weinberg; Brendan Curti; Bernard A Fox
Journal:  Semin Oncol       Date:  2010-10       Impact factor: 4.929

2.  Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells.

Authors:  Jaime A Tobar; Leandro J Carreño; Susan M Bueno; Pablo A González; Jorge E Mora; Sergio A Quezada; Alexis M Kalergis
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

3.  A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory.

Authors:  Alexander M Rowe; Susan E Murray; Hans-Peter Raué; Yoshinobu Koguchi; Mark K Slifka; David C Parker
Journal:  J Immunol       Date:  2013-09-04       Impact factor: 5.422

4.  Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.

Authors:  Shilpak Chatterjee; Paramita Chakraborty; Anusara Daenthanasanmak; Supinya Iamsawat; Gabriela Andrejeva; Libia A Luevano; Melissa Wolf; Uday Baliga; Carsten Krieg; Craig C Beeson; Meenal Mehrotra; Elizabeth G Hill; Jeffery C Rathmell; Xue-Zhong Yu; Andrew S Kraft; Shikhar Mehrotra
Journal:  Clin Cancer Res       Date:  2018-10-16       Impact factor: 12.531

5.  TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling.

Authors:  Ping Xie; Zachary J Kraus; Laura L Stunz; Yan Liu; Gail A Bishop
Journal:  J Immunol       Date:  2010-11-17       Impact factor: 5.422

Review 6.  B cell regulation of anti-tumor immune response.

Authors:  Yu Zhang; Richard Morgan; Eckhard R Podack; Joseph Rosenblatt
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

7.  B7-1 mediated costimulation regulates pancreatic autoimmunity.

Authors:  Deepak Yadav; Cody Fine; Miyuki Azuma; Nora Sarvetnick
Journal:  Mol Immunol       Date:  2007-02-07       Impact factor: 4.407

Review 8.  The role of OX40-mediated co-stimulation in T-cell activation and survival.

Authors:  William L Redmond; Carl E Ruby; Andrew D Weinberg
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

9.  Mast cell degranulation breaks peripheral tolerance.

Authors:  V C de Vries; A Wasiuk; K A Bennett; M J Benson; R Elgueta; T J Waldschmidt; R J Noelle
Journal:  Am J Transplant       Date:  2009-07-22       Impact factor: 8.086

10.  Effect of rosuvastatin on OX40L and PPAR-γ expression in human umbilical vein endothelial cells and atherosclerotic cerebral infarction patients.

Authors:  Jing-Yu Zhang; Bin Liu; Ya-Nan Wang; Wei-Na Zhang; Feng-Jun Wang
Journal:  J Mol Neurosci       Date:  2013-10-27       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.